Perampanel Hydrate is an anticonvulsant medication used as an adjunctive therapy for the treatment of partial-onset seizures and primary generalized tonic-clonic seizures in patients aged twelve and older.… Read more
Perampanel Hydrate is an anticonvulsant medication used as an adjunctive therapy for the treatment of partial-onset seizures and primary generalized tonic-clonic seizures in patients aged twelve and older. Belonging to the cyclopyrrolone class, this compound acts as a selective, non-competitive antagonist of the alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) glutamate receptor, effectively inhibiting neuronal excitability. This category provides access to high-quality reference standards, including pharmacopeial and non-pharmacopeial impurities, metabolites, and stable isotope-labelled compounds necessary for rigorous analytical testing. Pharmaceutical laboratories rely on these reference materials to perform accurate impurity profiling, method validation, and stability testing. By utilizing these precise standards, researchers can ensure compliance with quality control protocols throughout the drug development lifecycle, supporting the consistent manufacture and safety assessment of the therapeutic agent.